AG
ARRY

Advisor Group’s Array Biopharma Inc ARRY Stock Holding History

Advisor Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,229
Closed -$150K – 5586
2019
Q2 		$150K Sell
3,229
-1,641
-34% -$46.1K ﹤0.01% 2536
2019
Q1 		$118K Sell
4,870
-1,235
-20% -$25.7K ﹤0.01% 2724
2018
Q4 		$88K Buy
6,105
+1,720
+39% +$26.1K ﹤0.01% 2749
2018
Q3 		$68K Buy
4,385
+3,950
+908% +$60.5K ﹤0.01% 3062
2018
Q2 		$8K Sell
435
-740
-63% -$11.8K ﹤0.01% 4212
2018
Q1 		$19K Buy
1,175
+1,000
+571% +$16K ﹤0.01% 3726
2017
Q4 		$2K Hold
175
– – ﹤0.01% 4752
2017
Q3 		$2K Hold
175
– – ﹤0.01% 4608
2017
Q2 		$1K Sell
175
-300
-63% -$2.45K ﹤0.01% 4733
2017
Q1 		$5K Buy
475
+300
+171% +$3.19K ﹤0.01% 4150
2016
Q4 		$2K Hold
175
– – ﹤0.01% 4286
2016
Q3 		$1K Sell
175
-2,000
-92% -$7.74K ﹤0.01% 4408
2016
Q2 		$7K Buy
+2,175
New +$7.09K ﹤0.01% 3661

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Advisor Group's ARRY Position: Q3 2019 in Review

Advisor Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 3,229 shares — an estimated $150K sold.

Advisor Group first reported a position in ARRY in Q2 2016 and held it in 13 quarters. The position peaked at $150K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Advisor Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Advisor Group sold 3,229 Array Biopharma Inc shares in Q3 2019, an estimated $150K.
  • Advisor Group first reported a position in Array Biopharma Inc in Q2 2016 and held it in 13 quarters.
  • Advisor Group's Array Biopharma Inc position peaked at $150K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Advisor Group's 13F filing for Q3 2019, filed 13 Nov 2019.